FCGR2A/CD32A and FCGR3A/CD16A Variants andEULAR Response to Tumor Necrosis Factor-α Blockers in Psoriatic Arthritis: A Longitudinal Study with 6 Months of Followup.

Details

Language :

English

ISSN :

0315162X

Volume :

39

Issue :

5

Database :

Supplemental Index

Journal :

Journal of Rheumatology

Publication Type :

Academic Journal

Accession number :

95110834

Full Text :

https://doi.org/10.3899/jrheum.110980